Bio Path | BPTH - Equity Capital And Reserves


Bio Path reported $-7.16M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 22.81M 5.29M Jun/2023
Baxter International USD 6.13B 1.11B Dec/2025
Bio Path USD -7.16M 4.57M Jun/2025
Cipla INR 329.19B 16.3B Sep/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 43.83M 6.43M Sep/2025
CSL USD 18.66B 2.75B Dec/2025
Grifols EUR 6.08B 34.72M Sep/2025
Karyopharm Therapeutics USD -269.26M 30.33M Sep/2025